Catherine Truitt is an experienced BD&L professional with a background in biomedical engineering and over 20 years in the pharmaceuticals and medtech industries. They have held prominent roles, including Senior Director of External Innovation and Corporate Strategy at Alcon, where they oversaw deal execution and managed a portfolio of companies. Catherine's past experience includes consulting for Thea Laboratory and serving as a Principal Research Scientist at Ophthalmology Quinze-Vingt Hospital. They earned a Ph.D. from Université Paris 13 and have demonstrated expertise in ophthalmic pharmaceuticals, medical devices, and corporate strategy. Currently, they serve as the Head of the Alcon Seed Fund.
This person is not in the org chart
This person is not in any teams
This person is not in any offices